HEALEY ALS Platform Trial - Regimen C CNM-Au8

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen C will evaluate the safety and efficacy of a single study drug, CNM-Au8, in participants with ALS.
Epistemonikos ID: 1ec1f21fe5352c78e6e4ead1281db6b470fbd0e3
First added on: Dec 20, 2022